Trevi Therapeutics, Inc. - Common Stock (TRVI)
CUSIP: 89532M101
Q4 2019 13F Holders as of 31 Dec 2019
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 128,120,714
- Total 13F shares
- 14,179,323
- Share change
- -36,600
- Total reported value
- $53,174,000
- Price per share
- $3.75
- Number of holders
- 16
- Value change
- -$140,814
- Number of buys
- 3
- Number of sells
- 6
Quarterly Holders Quick Answers
What is CUSIP 89532M101?
CUSIP 89532M101 identifies TRVI - Trevi Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 89532M101:
Top shareholders of TRVI - Trevi Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TPG Group Holdings (SBS) Advisors, Inc. |
13F
|
Company |
4.9%
|
6,324,319
|
$28,459,000 | — | 30 Sep 2019 | |
| NEA Management Company, LLC |
13F
|
Company |
3.5%
|
4,441,360
|
$19,986,000 | — | 30 Sep 2019 | |
| Omega Fund Management, LLC |
13F
|
Company |
0.99%
|
1,263,408
|
$5,685,000 | — | 30 Sep 2019 | |
| FMR LLC |
13F
|
Company |
0.62%
|
792,700
|
$3,567,000 | — | 30 Sep 2019 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.55%
|
700,000
|
$3,150,000 | — | 30 Sep 2019 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.13%
|
168,810
|
$760,000 | — | 30 Sep 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.12%
|
150,432
|
$677,000 | — | 30 Sep 2019 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.1%
|
125,000
|
$563,000 | — | 30 Sep 2019 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.05%
|
60,535
|
$272,000 | — | 30 Sep 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
41,482
|
$186,000 | — | 30 Sep 2019 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.02%
|
24,565
|
$111,000 | — | 30 Sep 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.01%
|
16,480
|
$74,000 | — | 30 Sep 2019 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
2,344
|
$11,000 | — | 30 Sep 2019 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,577
|
$7,000 | — | 30 Sep 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0%
|
1,164
|
$5,000 | — | 30 Sep 2019 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0%
|
986
|
$4,000 | — | 30 Sep 2019 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0%
|
406
|
$2,000 | — | 30 Sep 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
114
|
$1,000 | — | 30 Sep 2019 |
Institutional Holders of Trevi Therapeutics, Inc. - Common Stock (TRVI) as of Q4 2019
As of 31 Dec 2019,
Trevi Therapeutics, Inc. - Common Stock (TRVI) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,179,323 shares.
The largest 10 holders included
TPG Group Holdings (SBS) Advisors, Inc., NEA Management Company, LLC, Omega Fund Management, LLC, FMR LLC, FRANKLIN RESOURCES INC, Schonfeld Strategic Advisors LLC, VANGUARD GROUP INC, DRIEHAUS CAPITAL MANAGEMENT LLC, Pinz Capital Management, LP, and BRIDGEWAY CAPITAL MANAGEMENT INC.
This page lists
16
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2019 vs Q3 2019 Across Filers
Q3 2019 holders
17
Q4 2019 holders
16
Holder diff
-1
| Investor | Q3 2019 Shares | Q4 2019 Shares | Share Diff | Share Chg % | Q3 2019 Value $ | Q4 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.